Van Loo Jan A E
Orafti NV, Tienen, Belgium.
J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S70-5. doi: 10.1097/01.mcg.0000128928.99037.e6.
The prebiotics concept, which was launched in 1995, concerns nondigested and selectively fermented carbohydrate food ingredients. It was thought that their effect in the colon could reduce risk for disease. The prebiotic concept is revisited and possible mechanisms are proposed. The physiologic consequences of prebiotic consumption are evaluated in terms of potential to reduce risk for disease. This is a compilation of several research papers, each of which complied with the World Medical Association Declaration of Helsinki.
For human dietary intervention trials, the aim was to perform double-blind, placebo-controlled, cross-over studies. A parallel design was used only for long-term studies. Most research has been done with beta(2-1) fructans, so they are used as an example of prebiotics here.
The results are relevant to the fields of gut function, lipid metabolism, mineral absorption, bone formation, immunology, and cancer.
It is observed that modification of intestinal flora by inherently selectively fermented prebiotics is central in determining their nutritional properties. They interact positively through the large intestinal surface with various physiologic processes and are thought to improve health status by reducing risk for disease (markers).
益生元的概念于1995年提出,涉及未消化的、可选择性发酵的碳水化合物食品成分。人们认为它们在结肠中的作用可以降低疾病风险。本文重新审视了益生元的概念并提出了可能的作用机制。从降低疾病风险的潜力方面评估了食用益生元的生理后果。这是几篇研究论文的汇编,每篇论文均符合世界医学协会的《赫尔辛基宣言》。
对于人体饮食干预试验,目标是进行双盲、安慰剂对照的交叉研究。平行设计仅用于长期研究。大多数研究是针对β(2-1)果聚糖进行的,因此这里将它们用作益生元的示例。
这些结果与肠道功能、脂质代谢、矿物质吸收、骨骼形成、免疫学和癌症等领域相关。
可以观察到,通过固有选择性发酵的益生元对肠道菌群的调节在决定其营养特性方面起着核心作用。它们通过大肠表面与各种生理过程产生积极相互作用,并被认为通过降低疾病风险(指标)来改善健康状况。